Temple Filler in Irvine, CA

Temple filler may suit patients with visible temporal hollowing, lateral brow descent from frame loss, or a tired upper-face appearance that is not corrected by under-eye or brow treatments alone.

Whether it is appropriate, and whether it should be combined with other treatments, depends on individual anatomy, vascular history, and the depth of the existing hollow.

Good fit: age-related volume loss with intact bone structure, mild to moderate temporal concavity, no history of prior temple filler complications.

Usually not enough on its own: severe global midface volume loss where the temple is one of many areas needing restoration. Also limited: significant brow ptosis driven by skin laxity rather than volume loss.

How Dr. Munib decides: palpation of the temporal fossa, identification of the temporal crest and vascular landmarks, review of prior filler history, and a conservative first-dose calibration with a 4-to-6-week recheck.

A temple filler appointment at Spectrum Skin Clinic takes 20 to 30 minutes. Dr. Munib palpates the temporal fossa, marks vascular landmarks, and places topical anesthesia. A blunt cannula is introduced at a single distal entry point per side, and the filler is deposited at the supraperiosteal plane in small, slow increments.

Immediate volume restoration is visible at the end of the session. Mild swelling resolves within 48 to 72 hours. Hyaluronic acid integrates with tissue over 4 to 6 weeks; the final temple shape is in place by week 6. Sculptra results build gradually over 3 to 6 months as collagen forms.

Duration depends on product: HA fillers last 12 to 18 months at the temple; Sculptra results last 18 to 24 months. With consistent maintenance, the dose required at each subsequent session tends to decrease as the temporal compartments remain partially supported.

Retrograde embolization from the superficial or middle temporal artery to the ophthalmic artery has been reported to cause partial or complete vision loss. Most documented cases involve a high-pressure bolus delivered through a sharp needle. Cannula technique, slow injection, and supraperiosteal placement markedly reduce — but do not eliminate — this risk. Immediate recognition and hyaluronidase administration may reverse partial vascular events.

The temporal fossa has a rich superficial vascular plexus. Bruising at the cannula entry or along the deposition path is common and typically resolves within 7 to 14 days. The Tyndall effect — a blue-grey discoloration through thin skin — can appear when HA filler is placed too superficially. Both are addressable with hyaluronidase if persistent.

A feminine temple should generally remain flush to mildly concave. Convexity through the temple can change facial character in ways that are difficult to reverse without dissolve. Conservative first-session dosing with a 4-to-6-week recheck is the safer path; aggressive single-session correction raises the risk of over-volumizing the lateral frame.

No downtime. Most patients return to normal activity the same day.

First few hours: stay upright; avoid pressing or massaging the treated area; do not lie flat or face-down.

First 48 hours: skip strenuous exercise, saunas, and alcohol to limit swelling and bruising.

First 2 weeks: report any vision changes, severe pain, skin blanching, or unusual bruising immediately — these may indicate vascular involvement and require prompt evaluation.

Full result: HA results settle by week 6; Sculptra results build over 3 to 6 months.

Priced per syringe. Temple filler typically uses 0.5 to 1 mL per side at the first session, with total volumes of 1 to 2 mL across both temples.

Total depends on three factors. First: which filler is selected (HA vs collagen-stimulator). Second: how much volume is needed bilaterally. Third: whether the plan includes combination with another area such as lateral brow Botox or cheek filler.

First-time patients are started at the lower end of the volume range with a 4-to-6-week recheck before any additional product is placed. Dr. Munib confirms the estimate at the consultation.

Restoring temporal volume supports the lateral brow at its frame, which can produce a mild but real lift of the lateral brow and a less hooded upper-eye appearance. The effect is most visible in patients whose lateral brow descent is driven by temporal volume loss rather than skin laxity.

The lift is anatomical, not surgical. It restores the support the brow had before the temporal compartments atrophied, rather than physically pulling tissue upward. Patients with significant brow ptosis from dermatochalasis or skin laxity may need additional treatment (Botox, RF tightening, or surgical referral) for full correction.

Dr. Munib evaluates the brow-temple relationship at consultation and discusses realistic expectations for the lateral lift effect based on the patient's anatomy.